Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GLIDE Oil (also marketed as GLIDE+) is a cannabis-based topical Ayurvedic oil developed by BOHECO (Bombay Hemp Company) for the symptomatic relief of arthritis, joint pain, and osteoarthritis. Formulated with a 3X concentration of Cannabis Leaf Extract (Cannabis sativa L.) and Hemp Seed Oil, it acts locally on the body's endocannabinoid system (ECS) by interacting with cannabinoid receptors CB1 and CB2. This interaction helps reduce pain signaling, soothe joint inflammation, ease stiffness, and support improved joint movement and lubrication. It is designed for consistent, long-term joint care and is applied topically via gentle massage to the affected areas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GLIDE Oil.